Skip to main content
. Author manuscript; available in PMC: 2018 Jul 31.
Published in final edited form as: J Infect Dev Ctries. 2012 Dec 15;6(12):870–880. doi: 10.3855/jidc.2636

Table 1.

Inclusion and exclusion criteria for the Kisumu Incidence Cohort Study, Kisumu, Kenya, 2007–2008

Inclusion criteria
Male and female residents of the Kisumu catchment area
Age 18 to 34 years
Engagement in sexual activity ≥ one time within the past 3 months
HIV seronegative by licensed rapid HIV testing in parallel
Available for 12 months of participation in the study
Able and willing to provide informed consent
Able to provide detailed locator information to ensure adequate, timely follow-up
Meet the following laboratory criteria: serum creatinine < 1.5mg/dl, haemoglobin ≥ 9.0g/dl, platelets > 50,000/ml, ALT <
2.5 times the upper limit of normal
Willing to comply with study procedures and requirements if meet criteria for study eligibility
Exclusion criteria
HIV seropositive
Pregnant or plan to become pregnant in next 12 months if female
Plan to reside outside the Kisumu catchment area for >3 months
Evidence of clinically significant cardiac, respiratory, hepatic, gastrointestinal, endocrine, hematologic, psychiatric,
neurologic, or allergic disease that would compromise the ability of the participant to provide competent informed consent,
or to complete study procedures or study requirements as determined by the principal investigator or designated associate.
The clinical significance of any abnormality is to be evaluated in the context of the safety of the patient volunteer and the
objectives of this study.
Active participation in HIV intervention studies that might influence HIV incidence or risk behaviour